Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

about

Treatment of functional GI disease: the complex pharmacology of serotonergic drugs. Reply from author.

P2860

Q46056837-22E14ADF-33C1-4F3C-B67E-1650098A2124

P2860

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

Item

http://www.wikidata.org/entity/Q42780042

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@en

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@nl

type

Item

label

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@en

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@nl

prefLabel

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@en

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@nl

P1476

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

@en

P2093

Francesca Crema

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: cardiac adverse effects of gastrointestinal prokinetics.

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus.

Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles.

Serotonergic modulating drugs for functional gastrointestinal diseases.

Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists.

Do human atrial 5-HT4 receptors mediate arrhythmias?

Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.

Quantifying the 5-HT1A agonist action of buspirone in man.

P304

680-1; author reply 681-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.2002.01703.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizio De Ponti

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10981126

http://www.w3.org/2001/XMLSchema#string

P698

12492621

http://www.w3.org/2001/XMLSchema#string

P932

1874486

http://www.w3.org/2001/XMLSchema#string

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

about

P2860

P2860

Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932